vs

Side-by-side financial comparison of BICYCLE THERAPEUTICS PLC (BCYC) and FTC Solar, Inc. (FTCI). Click either name above to swap in a different company.

BICYCLE THERAPEUTICS PLC is the larger business by last-quarter revenue ($48.0M vs $32.9M, roughly 1.5× FTC Solar, Inc.). BICYCLE THERAPEUTICS PLC runs the higher net margin — -42.0% vs -110.7%, a 68.7% gap on every dollar of revenue. On growth, BICYCLE THERAPEUTICS PLC posted the faster year-over-year revenue change (1193.3% vs 148.9%). FTC Solar, Inc. produced more free cash flow last quarter ($-8.4M vs $-19.9M). Over the past eight quarters, FTC Solar, Inc.'s revenue compounded faster (61.6% CAGR vs 56.7%).

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical firm developing innovative bicyclic peptide therapies for unmet medical needs. Its core pipeline covers oncology, rare diseases, and immunological disorders, with operations in Europe and North America, and partnerships with global pharma leaders to advance drug candidates to market.

FTC Solar, Inc. is a leading global provider of advanced solar tracker systems, associated components, and supporting software for solar projects. It serves utility-scale, commercial, and industrial solar segments across key global markets, helping customers boost energy generation efficiency and lower overall project costs.

BCYC vs FTCI — Head-to-Head

Bigger by revenue
BCYC
BCYC
1.5× larger
BCYC
$48.0M
$32.9M
FTCI
Growing faster (revenue YoY)
BCYC
BCYC
+1044.4% gap
BCYC
1193.3%
148.9%
FTCI
Higher net margin
BCYC
BCYC
68.7% more per $
BCYC
-42.0%
-110.7%
FTCI
More free cash flow
FTCI
FTCI
$11.5M more FCF
FTCI
$-8.4M
$-19.9M
BCYC
Faster 2-yr revenue CAGR
FTCI
FTCI
Annualised
FTCI
61.6%
56.7%
BCYC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BCYC
BCYC
FTCI
FTCI
Revenue
$48.0M
$32.9M
Net Profit
$-20.2M
$-36.4M
Gross Margin
14.9%
Operating Margin
-51.5%
-17.2%
Net Margin
-42.0%
-110.7%
Revenue YoY
1193.3%
148.9%
Net Profit YoY
61.1%
-197.4%
EPS (diluted)
$-0.29
$-2.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCYC
BCYC
FTCI
FTCI
Q4 25
$48.0M
$32.9M
Q3 25
$11.7M
$26.0M
Q2 25
$2.9M
$20.0M
Q1 25
$10.0M
$20.8M
Q4 24
$3.7M
$13.2M
Q3 24
$2.7M
$10.1M
Q2 24
$9.4M
$11.4M
Q1 24
$19.5M
$12.6M
Net Profit
BCYC
BCYC
FTCI
FTCI
Q4 25
$-20.2M
$-36.4M
Q3 25
$-59.1M
$-23.9M
Q2 25
$-79.0M
$-15.4M
Q1 25
$-60.8M
$-3.8M
Q4 24
$-12.2M
Q3 24
$-50.8M
$-15.4M
Q2 24
$-39.8M
$-12.2M
Q1 24
$-26.6M
$-8.8M
Gross Margin
BCYC
BCYC
FTCI
FTCI
Q4 25
14.9%
Q3 25
6.1%
Q2 25
-19.6%
Q1 25
-16.6%
Q4 24
-29.1%
Q3 24
-42.5%
Q2 24
-20.5%
Q1 24
-16.7%
Operating Margin
BCYC
BCYC
FTCI
FTCI
Q4 25
-51.5%
-17.2%
Q3 25
-558.6%
-29.6%
Q2 25
-2965.8%
-57.5%
Q1 25
-703.7%
-50.8%
Q4 24
-101.7%
Q3 24
-2385.9%
-147.8%
Q2 24
-498.3%
-104.3%
Q1 24
-162.4%
-99.3%
Net Margin
BCYC
BCYC
FTCI
FTCI
Q4 25
-42.0%
-110.7%
Q3 25
-503.7%
-92.0%
Q2 25
-2703.8%
-77.2%
Q1 25
-608.9%
-18.4%
Q4 24
-92.7%
Q3 24
-1898.4%
-151.5%
Q2 24
-425.3%
-107.1%
Q1 24
-136.0%
-69.7%
EPS (diluted)
BCYC
BCYC
FTCI
FTCI
Q4 25
$-0.29
$-2.31
Q3 25
$-0.85
$-1.61
Q2 25
$-1.14
$-1.18
Q1 25
$-0.88
$-0.58
Q4 24
$-0.95
Q3 24
$-0.74
$-1.21
Q2 24
$-0.77
$-0.97
Q1 24
$-0.62
$-0.70

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCYC
BCYC
FTCI
FTCI
Cash + ST InvestmentsLiquidity on hand
$628.1M
$21.1M
Total DebtLower is stronger
$9.9M
Stockholders' EquityBook value
$610.0M
$-43.0M
Total Assets
$717.6M
$111.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCYC
BCYC
FTCI
FTCI
Q4 25
$628.1M
$21.1M
Q3 25
$648.3M
$24.4M
Q2 25
$721.5M
$3.5M
Q1 25
$793.0M
$5.9M
Q4 24
$879.5M
$11.2M
Q3 24
$890.9M
$8.3M
Q2 24
$961.4M
$10.8M
Q1 24
$457.0M
$14.0M
Total Debt
BCYC
BCYC
FTCI
FTCI
Q4 25
$9.9M
Q3 25
$16.6M
Q2 25
$10.9M
Q1 25
$10.2M
Q4 24
$9.5M
Q3 24
Q2 24
$30.9M
Q1 24
$30.8M
Stockholders' Equity
BCYC
BCYC
FTCI
FTCI
Q4 25
$610.0M
$-43.0M
Q3 25
$618.5M
$-13.7M
Q2 25
$668.9M
$9.0M
Q1 25
$740.3M
$15.5M
Q4 24
$793.1M
$19.0M
Q3 24
$831.0M
$30.4M
Q2 24
$873.8M
$44.2M
Q1 24
$356.0M
$55.2M
Total Assets
BCYC
BCYC
FTCI
FTCI
Q4 25
$717.6M
$111.8M
Q3 25
$764.0M
$111.5M
Q2 25
$832.2M
$83.0M
Q1 25
$883.9M
$84.1M
Q4 24
$956.9M
$89.9M
Q3 24
$996.7M
$91.7M
Q2 24
$1.1B
$100.3M
Q1 24
$547.1M
$115.0M
Debt / Equity
BCYC
BCYC
FTCI
FTCI
Q4 25
Q3 25
Q2 25
1.20×
Q1 25
0.65×
Q4 24
0.50×
Q3 24
Q2 24
0.04×
Q1 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCYC
BCYC
FTCI
FTCI
Operating Cash FlowLast quarter
$-19.3M
$-8.0M
Free Cash FlowOCF − Capex
$-19.9M
$-8.4M
FCF MarginFCF / Revenue
-41.5%
-25.7%
Capex IntensityCapex / Revenue
1.2%
1.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-252.0M
$-34.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCYC
BCYC
FTCI
FTCI
Q4 25
$-19.3M
$-8.0M
Q3 25
$-71.2M
$-14.6M
Q2 25
$-72.8M
$-2.3M
Q1 25
$-86.4M
$-8.5M
Q4 24
$-164.7M
$-16.7M
Q3 24
$-39.8M
$-2.4M
Q2 24
$-44.6M
$-3.8M
Q1 24
$-70.9M
$-11.9M
Free Cash Flow
BCYC
BCYC
FTCI
FTCI
Q4 25
$-19.9M
$-8.4M
Q3 25
$-71.8M
$-15.1M
Q2 25
$-73.3M
$-2.5M
Q1 25
$-87.0M
$-8.6M
Q4 24
$-166.0M
$-17.0M
Q3 24
$-40.3M
$-2.6M
Q2 24
$-45.0M
$-4.5M
Q1 24
$-70.9M
$-12.3M
FCF Margin
BCYC
BCYC
FTCI
FTCI
Q4 25
-41.5%
-25.7%
Q3 25
-612.3%
-57.9%
Q2 25
-2509.7%
-12.4%
Q1 25
-871.7%
-41.2%
Q4 24
-4475.7%
-128.6%
Q3 24
-1504.7%
-25.6%
Q2 24
-481.2%
-39.2%
Q1 24
-362.9%
-97.6%
Capex Intensity
BCYC
BCYC
FTCI
FTCI
Q4 25
1.2%
1.3%
Q3 25
5.7%
1.7%
Q2 25
17.1%
0.9%
Q1 25
6.1%
0.4%
Q4 24
33.3%
2.2%
Q3 24
16.3%
2.2%
Q2 24
4.5%
6.1%
Q1 24
0.1%
3.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BCYC
BCYC

Segment breakdown not available.

FTCI
FTCI

Products$26.2M80%
Services$6.7M20%

Related Comparisons